Establishment of the new strategy with REIC/Dkk-3 against androgen independent prostate cancer.
Project/Area Number |
15K07754
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Veterinary medical science
|
Research Institution | Nippon Veterinary and Life Science University |
Principal Investigator |
Ochiai Kazuhiko 日本獣医生命科学大学, 獣医学部, 准教授 (30550488)
|
Co-Investigator(Kenkyū-buntansha) |
呰上 大吾 日本獣医生命科学大学, 獣医学部, 准教授 (80453934)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 前立腺がん / REIC/Dkk-3 / SGTA / イヌ / ホルモン療法抵抗性 / ARシグナル伝達 |
Outline of Final Research Achievements |
The pathological condition of canine prostate cancer resembles that of human androgen-independent prostate cancer. Both canine and human androgen receptor (AR) signalling are inhibited by overexpression of the dimerized co-chaperone SGTA, which is considered to cause the development of androgen-independency. REIC interferes with SGTA dimerization and rescues AR signalling. This study aimed to assess the effects of REIC and SGTA interactions on AR signalling in the canine androgen-independent prostate cancer cell line CHP-1. MTH and Halo-tag PD assays showed that canine REIC interacted with SGTA and interfered with SGTA dimerization. Additionally, reporter assays revealed that canine REIC restored AR signalling. Therefore, we confirmed the interaction between canine SGTA and REIC, as well as their role in AR signalling. Our results suggest that this interaction might contribute to the development of a novel strategy for androgen-independent prostate cancer treatment.
|
Report
(4 results)
Research Products
(17 results)
-
-
-
-
[Journal Article] Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3).2017
Author(s)
Ochiai K, Oda H, Shono S, Kato Y, Sugihara S, Nakazawa S, Azakami D, Michishita M, Onozawa E, Bonkobara M, Sako T, Shun-Ai L, Ueki H, Watanabe M, Omi T.
-
Journal Title
Vet Comp Oncol
Volume: In press
Issue: 4
Pages: 1181-1186
DOI
Related Report
Peer Reviewed
-
[Journal Article] Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity2016
Author(s)
Ochiai K, Morimatsu M, Kato Y, Ishiguro-Oonuma T, Udagawa C, Rungsuriyawiboon O, Azakami D, Michishita M, Ariyoshi Y, Ueki H, Nasu Y, Kumon H, Watanabe M, Omi T.
-
Journal Title
Oncotarget
Volume: 7
Issue: 3
Pages: 3283-3296
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α2016
Author(s)
Azakami, D., Nakahira, R., Kato, Y., Michishita, M., Kobayashi, M., Onozawa, E., Bonkobara, M., Kobayashi, M., Takahashi, K., Watanabe, M., Ishioka, K., Sako, T., Ochiai, K., and Omi, T.
-
Journal Title
Veterinary and Compapative Oncology
Volume: 印刷中
Issue: 2
Pages: 557-562
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.2015
Author(s)
Kato, Y., Ochiai, K., Michishita, M., Azakami, D., Nakahira, R., Morimatsu, M., Ishiguro-Oonuma, T., Yoshikawa, Y., Kobayashi, M., Bonkobara, M., Kobayashi, M., Takahashi, K., Watanabe, M., and Omi, T.
-
Journal Title
The Vwterinary Journal
Volume: 206
Issue: 2
Pages: 145-148
DOI
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-